关键数据
7.160今开
7.260最高
0.00成交量
2.90市盈率 TTM
49.75市盈率动
--股息TTM
0.06%换手率
7.150昨收
6.975最低
0.00成交额
亏损市盈率静
5.84市净率
0.00%股息率 TTM
42.24%ROA
12.94052周最高
0.10量比
-31.40M净利润
12.28M总股本
2.4434每股收益TTM
1.07Beta
-16631.70%ROE
4.95052周最低
4.14%振幅
48.63%毛利率
87.80M总市值
13.41回报/风险
4.24%风险率

即将为您带来更多新闻,敬请期待。。。
LENSAR Inc评分
-0.05与上次评分对比预测9.00
财务诊断7.20
技术分析4.33
公司估值9.69
机构认同度5.00
风险评估3.01
分析师评级
强力买入评级
11.000目标均价
+51.72%涨幅空间
LENSAR Inc 最新财报电话会记录
LENSAR 2026年第二季度业绩电话会议:经常性销售额增长推动营收增长18%
LENSAR在2026年第二季度财报电话会议上详细介绍了18%的营收增长、1,370万美元的经常性收入、创纪录的调整后EBITDA以及ALLY系统的持续采用。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
LENSAR Inc 简介
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
行业医疗设备与耗材
公司代码LNSR
员工数量140
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| North Run Capital, LP | 9.35% |
|---|
| Brandes Investment Partners, L.P. | 7.07% |
|---|
| Curtis (Nicholas T) | 7.06% |
|---|
| BlackRock Institutional Trust Company, N.A. | 4.84% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 27.45% |
|---|
| Individual Investor | 21.79% |
|---|
| Hedge Fund | 11.93% |
|---|
| Investment Advisor/Hedge Fund | 7.97% |
|---|
常见问题
LENSAR Inc(LNSR)的当前股价是多少?
LENSAR Inc(LNSR)的当前股价是 7.15。
LENSAR Inc股票的52周最高点是12.94。
LENSAR Inc股票的52周最低点是4.95。
现在LENSAR Inc(LNSR)的股票是买入、持有还是卖出?
根据分析师评级,LENSAR Inc(LNSR)的总体评级为STRONG BUY,目标价格为11.00。
LENSAR Inc(LNSR)股票的每股收益(EPS TTM)是多少
LENSAR Inc(LNSR)股票的每股收益(EPS TTM)是2.44。